- Home
- MLYS vs PML Comparison
MLYS vs PML Comparison
Compare MLYS & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLYS | PML |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 502.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLYS | PML |
|---|---|---|
| Price | $35.70 | $7.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $47.33 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 188.0K |
| Earning Date | 02-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.24 | $6.92 |
| 52 Week High | $47.65 | $9.46 |
Technical Indicators
Market Signals| Indicator | MLYS | PML |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 47.87 |
| Support Level | $34.21 | $7.45 |
| Resistance Level | $36.61 | $7.64 |
| Average True Range (ATR) | 1.35 | 0.05 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 35.56 | 71.05 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.